KBC Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-456,087
Closed -$5.03M 1281
2017
Q1
$5.03M Buy
+456,087
New +$6.27M 0.05% 401
2016
Q2
Sell
-4,467
Closed -$117K 1283
2016
Q1
$117K Buy
+4,467
New +$330K ﹤0.01% 1120
2015
Q4
Sell
-1,942
Closed -$346K 1264
2015
Q3
$346K Sell
1,942
-22,480
-92% -$5.24M 0.01% 861
2015
Q2
$5.42M Buy
24,422
+396
+2% +$87.8K 0.07% 314
2015
Q1
$4.77M Buy
24,026
+14,019
+140% +$2.49M 0.06% 323
2014
Q4
$1.43M Buy
+10,007
New +$1.35M 0.02% 667
2014
Q3
Sell
-5,094
Closed -$642K 1288
2014
Q2
$642K Sell
5,094
-20,677
-80% -$2.64M 0.01% 859
2014
Q1
$3.4M Buy
25,771
+9,559
+59% +$1.31M 0.05% 375
2013
Q4
$1.9M Buy
16,212
+9,986
+160% +$1.09M 0.03% 524
2013
Q3
$650K Buy
+6,226
New +$607K 0.01% 768

Other funds holding BHC

KBC Group's BHC Position: Q2 2017 in Review

KBC Group sold out of Bausch Health (BHC) in Q2 2017, closing a stake of 456,087 shares — an estimated $5.03M sold.

KBC Group first reported a position in BHC in Q3 2013 and held it in 10 quarters. The position peaked at $5.42M in Q2 2015. 317 funds tracked by Wall St. Rank hold BHC as of Q2 2017.

  • KBC Group reported no remaining Bausch Health position as of Q2 2017 after selling out during the quarter.
  • KBC Group sold 456,087 Bausch Health shares in Q2 2017, an estimated $5.03M.
  • KBC Group first reported a position in Bausch Health in Q3 2013 and held it in 10 quarters.
  • KBC Group's Bausch Health position peaked at $5.42M in Q2 2015.
  • 317 funds tracked by Wall St. Rank held Bausch Health as of Q2 2017.

Based on KBC Group's 13F filing for Q2 2017, filed 4 Aug 2017.